CompletedN/ALSD

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

Sponsored by Psychiatric University Hospital, Zurich

NCT ID
NCT02451072
Target Enrollment
25 participants
Start Date
2015-03
Est. Completion
2016-01

About This Study

Aim of the present study is to investigate the neuronal correlates of self and of personal meaning as well as the role of the serotonin (5-HT) 2A receptor system in these processes using functional magnetic resonance imaging (fMRI) and psychometric and cognitive measures.

Conditions Studied

Healthy

Interventions

  • Placebo
  • LSD
  • Ketanserin

Eligibility

Age:20 Years - 40 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Healthy male and female volunteers at the age of 20-40
* Willing and capable to give informed consent for study participation as documented by signature after the nature of the study has been thoroughly explained
* Willing to refrain from drinking alcohol the day before testing session, from drinking alcohol and caffeinated drinks at the testing days and from consuming psychoactive substances 2 weeks before testing days and for the duration of the study
* Able and willing to comply with all study requirements
* MRI-compatible body shape and size (Body mass index \[BMI\] 17-30)
* Right-handedness

Exclusion Criteria:

* Poor knowledge of the German language
* Previous significant adverse response to a hallucinogenic drug
* Participation in another study where pharmaceutical compounds are given within the 30 days preceding and during the present study
* Self or first-degree relatives with present or antecedent psychiatric disorders
* Present or antecedent alcohol/drug dependence or present alcohol/drug abuse
* History of head trauma, fainting, seizures, or electroconvulsive therapy
* Recent cardiac or brain surgery
* Current use of medication known to affect brain function (e.g. benzodiazepines, antihistamines, aspirin, beta blockers, theophylline, acetazolamide, etc.)
* Concomitant therapy with potent inhibitors of cytochrome P-450 isoenzyme 3A4 (HIV protease inhibitors, macrolide antibiotics, acylderivative anti-infective agents)
* Presence of major internal or neurological disorders (including sepsis, pheochromocytoma, thyrotoxicosis, drug-induced fibrosis, familiar or basilar artery migraine)
* Presence of psychiatric disorder
* Cardiovascular disease (hypertonia, coronary artery disease, heart insufficiency, myocardial infarction within the past 6 months, coronary spastic angina)
* Peripheral vascular disease (thromboangiitis obliterans, luetic arteritis, severe arteriosclerosis, thrombophlebitis, Raynaud's disease)
* Liver or renal disease
* Pregnant or breastfeeding women (a urine pregnancy test will be done before each session for all women capable of bearing children)
* Inability to lie still for about 60 minutes (e.g. because of sneezing, itching, tremor, pain)
* Metal parts in the body (piercings, brain aneurysm clip, implanted neural stimulator/cardiac pacemaker/defibrillator/Swan Ganz catheter/insulin pump, cochlear implant); metal shrapnel or bullet, ocular foreign body (e.g. metal shavings); current or previous job in metalworking industry
* Claustrophobia

Study Locations (1)

Center for Psychiatric Research, Department of Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich
Zurich, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers | Huxley